A novel gene-based prognostic tool for personalized treatment in pediatric acute myeloid leukemia

by

As our understanding of AML biology, cytogenetic and molecular profiles, and the emergence of new treatment options continues to evolve, it becomes imperative to adapt prognostic tools accordingly.

Leave A Comment

Your email address will not be published. Required fields are marked *